Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05393258 · ClinicalTrials.gov registry record · NA
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
A NA study of Astrocytoma and Glioma, Malignant, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT05393258 is a NA study of Astrocytoma and Glioma, Malignant that has completed, run by Washington University School of Medicine. The registered enrollment target is 13 participants, below the 49-participant average among 19 other Astrocytoma trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05393258, a NA study of Astrocytoma and Glioma, Malignant, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies the side effects of temporally-modulated pulsed radiation therapy (TMPRT) in patients with IDH-mutant gliomas who have previously received radiation therapy to the brain. TMPRT is a radiation technique in which radiation is delivered in multiple small doses on a specific timed interval, instead of delivering one large dose at one time. This technique may improve efficacy while reducing toxicity and improving patient quality of life.
Conditions Studied
Interventions
- RADIATION temporally-modulated pulsed radiotherapy (TMPRT)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-06-28 |
| Est. Completion | 2026-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05393258
The ClinicalTrials.gov registry entry for NCT05393258 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 49-participant average among 19 other Astrocytoma trials with a reported enrollment target (73% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Astrocytoma appearing as the primary indexed condition, and to 1 intervention - of which temporally-modulated pulsed radiotherapy (TMPRT) is the first listed.
NCT05393258 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05393258 about?
NCT05393258 is a clinical study titled "Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas". This clinical trial studies the side effects of temporally-modulated pulsed radiation therapy (TMPRT) in patients with IDH-mutant gliomas who have previously received radiation therapy to the brain. TMPRT is a radiation technique in which radiation is delivered in multiple small doses on a specific ...
What is the current status of trial NCT05393258?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-06-28. Estimated completion is 2026-03-13.
What conditions does trial NCT05393258 study?
This clinical trial studies the following conditions: Astrocytoma, Glioma, Malignant, Oligodendroglioma, Adult.
What interventions are being tested in trial NCT05393258?
The interventions under investigation include: temporally-modulated pulsed radiotherapy (TMPRT) (RADIATION).
Who is sponsoring clinical trial NCT05393258?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05393258 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astrocytoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
RECRUITING · NA
-
FearLess in NeuroOncology
RECRUITING · NA
-
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
ACTIVE NOT RECRUITING · NA
-
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
RECRUITING · Phase 2
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
Implantable Microdevice In Primary Brain Tumors
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.